Navigation Links
AMT Announces Presentations During the 11th Annual Meeting of the ASGT
Date:5/28/2008

AMSTERDAM, May 28 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a series of presentations during the 11th Annual Meeting of the American Society of Gene Therapy in Boston, including a presentation on the pivotal clinical trial with its lead product AMT-011 on May 29.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.

Certain statements in this press release are "forward-looking statements" including those that refer to management's plans and expectations for future operations, prospects and financial condition. Words such as "strategy," "expects," "plans," "anticipates," "believes," "will," "continues," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning are intended to identify such forward-looking statements. Such statements are based on the current expectations of the management of Amsterdam Molecular Therapeutics only. Undue reliance should not be placed on these statements because, by their nature, they are subject to known and unknown risks and can be affected by factors that are beyond the control of AMT. Actual results could differ materially from current expectations due to a number of factors and uncertainties affecting AMT's business, including, but not limited to, the timely commencement
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... ... its technology platform to support large projects. , ... (PRWEB) January 21, 2010 -- Firmex, the leader in ... to its technology platform. , , , , ,Firmex has released a new architecture ...
... ... development capacity drives PCT to open new facility , ... Allendale, NJ (Vocus) January 22, 2010 -- Progenitor Cell Therapy, LLC ... , , , , ,The company’s new cell therapy development and manufacturing ...
... ... SINGAPORE , January 22 , ... Together for Honors , Elsevier announced today the winners ... Scopus(R), the,world,s largest abstract and citation database of peer-reviewed literature,and the Third World ...
Cached Biology Technology:Firmex Announces Virtual Data Room Enhancements for Large Projects 2Firmex Announces Virtual Data Room Enhancements for Large Projects 3Progenitor Cell Therapy Expands Manufacturing Operations 2Progenitor Cell Therapy Expands Manufacturing Operations 3Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 2Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 3Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 4Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 5Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 6Scopus(R), TWOWS and TWAS Announce Young Women Researcher Award Recipients in Asia 7
(Date:4/15/2014)... deforestation could cause temperatures in the Congo Basin ... intensify warming caused by greenhouse gases by half, ... University of Leuven, Belgium. , Explosive population growth ... of tropical rainforests in Central Africa. A team ... how these practices will affect longer-term temperatures in ...
(Date:4/15/2014)... IL (April 15, 2014) New research published ... of the American College of Nutrition shows whey ... or as part of a weight-loss or weight-maintenance diet, ... composition. , The meta-analysis included 14 randomized controlled ... researchers analyzed those weight loss studies that used whey ...
(Date:4/14/2014)... the greenhouse gas methane were found above shale gas ... an important emissions source, according to a study jointly ... have implications for the evaluation of the environmental impacts ... one of only a few to use a so-called ... the air above wells, identified seven individual well pads ...
Breaking Biology News(10 mins):Study: Deforestation could intensify climate change in Congo Basin by half 2New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3'Problem wells' source of greenhouse gas at unexpected stage of natural gas production 2
... African Americans known to potentially cause hypertension, found Michael ... in the September issue of Experimental Physiology. Brown is ... of Health Professions. The hormone, aldosterone, influences the ... it can contribute to the development of hypertension because ...
... Enjoying your August vacation? Well, (as they say in the ... has been consistently quiet, sudden, and deadly. Unknowingly, we have ... rock -- you personally are not in any danger. Its ... be an accomplice. Melodrama aside, the threat is very ...
... For years, scientists have known that some people are biologically ... only been able to speculate why. In the August ... the University of Chicago report on a study that may ... rats most likely to self-administer addictive drugs had a particular ...
Cached Biology News:Understanding hypertension in African Americans proves elusive 2Humans fostering forest-destroying disease 2Humans fostering forest-destroying disease 3Humans fostering forest-destroying disease 4Nicotinic receptors may be important targets for treatment of multiple addictions 2
... Combining linear motor and ballscrew ... pre-engineered Cartesian solutions that include ... management, and motors., , ... Pass through high-flex cabling for ...
UGT1A6 (D-20)...
... T Squareds patented high efficiency dynamic valve ... With the most compact, lightweight package in ... use in portable air and gas applications., ... high efficiency. , Includes DC Motor. ...
... designed for moving loads quickly and accurately. ... output while limiting overall size. The P5S-P ... ball bearings guided on two rails., ... provide energy absorption and controlled deceleration , ...
Biology Products: